Description
Fragment 176-191 5mg
Fragment 176-191 is a peptide that is a modified version of amino acids 176-191. It is sometimes referred to as Frag 176-191, Cytoplasmic Protein 9.5, or Gracile Axonal Dystrophy.
Fragment 176-191 at a Glance
According to scientific study that has been based on animal test subjects, Fragment 176-191 has been shown to possess the ability to stimulate the process of lipolysis and slow down the process of lipogenesis. What’s more, it has been determined that the peptide’s functionality is very selective in the sense that it will only work with obese cells in order to release fat. This has led to the notion that the peptide could play a key role in enabling an animal test subject to experience a more efficient means of weight loss. It has also shown that the peptide has the capacity to boost blood glucose levels over a short period of time, and can enable a longer lasting boost of insulin levels to occur, provided that the peptide’s sequential chain is arranged correctly.
Fragment 176-191 and Mental Degradation
Additional scientific study based on animal test subjects has determined that there may be a link between Fragment 176-191, mental preservation and mental degradation – specifically as it relates to Alzheimer’s and Parkinson’s disease. It is thought that the presence of the peptide could conceivably play a part in prohibiting the kind of basal lesions that have been determined to contribute to the onset of Parkinson’s disease. It has also been thought that the peptide could offset the levels of toxicity that stem from the kind of protein malfunctions present at the onset of Alzheimer’s.
Strictly for Controlled Environments
It should be noted that any findings or observations that relate to Fragment 176-191 and its overall functionality should exclusively be done within a strictly controlled environment, such as a medical research facility or a laboratory. Research that has been derived regarding Fragment 176-191 is due to scientific tests conducted in a controlled environment only.
